The anti-impotence drug Viagra may help save people with muscular dystrophy from an early death, a study suggests.

Researchers found the way the drug works to combat impotence may also help ward off heart failure in muscular dystrophy patients.

Tests on mice with a version of the disease showed the drug helped keep their hearts working well.

The Montreal Heart Institute study appears in Proceedings of the National Academy of Sciences.

Latest news - 25-04-2008 ...
'Pressure tactics' ...
Czech scientists can reduce amount of harmful substances in air ...
Children thrown from burning flat ...

Muscular dystrophy is a genetic condition which affects boys, and causes wasting of the muscles.

People with the condition are at a higher risk of heart failure due to a weakening of the muscles which keep the organ pumping strongly.

For this reason, many people with muscular dystrophy die in early life, often in their 20s or 30s.

Blood flow

The Montreal team found that Viagra - known technically as sildenafil - prevents the loss of a molecule, cGMP, which plays a key role in keeping blood vessels dilated.

In the penis, this increases blood flow, and helps to combat impotence.

But in the heart it helps to insure the organ itself receives a proper supply of blood, and remains healthy and strong.

With the heart in a strong condition, it is more able to withstand the impact of weakening muscle cells caused by muscular dystrophy.

Viagra works by blocking an enzyme, PDE5, which breaks down cGMP.

The researchers also inserted a gene that increased cGMP production in the mice's heart cells, and found that this helped the animals to maintain normal cardiac function.

Dr Marita Pohlschmidt, director of research at the Muscular Dystrophy Campaign, said the research was interesting.

However, she added: "It is important to remember that benefits seen in animals do not always translate into human medicine.

"Although this is promising, it is still very early days and we look forward to further research that will demonstrate the impact it might have for people with muscular dystrophy."

(BBC)

<< Back